---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-25-013743"
form_type: "8-K"
ticker: "MBOT"
cik: "0000883975"
company_name: "Microbot Medical Inc."
filed_at: "2025-09-16T23:59:59+00:00"
generated_at: "2026-05-17T06:35:15.956810+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Microbot Medical raises $25.2M in first close of PIO exercise; potential total $92.2M

## Summary
- First closing on Sep 16 generated ~$25.2M gross; second closing expected by Oct 15 for ~$4M.
- Issued new Series J PIOs to purchase up to 13.99M shares at $4.50/share (exercise starts 6 mo, 2-yr term).
- Existing PIOs exercised at $1.50-$2.13/share; new PIOs at $4.50/share, providing potential $63M if fully cashed.
- Proceeds to be used for LIBERTY Robotic System development, M&A, IP expansion, and working capital.
- On Sep 8, 2025, issued 225k shares upon Series H PIO exercise for $472,500 gross proceeds.

## SEC filing metadata
- accession: 0001493152-25-013743
- form_type: 8-K
- ticker: MBOT
- cik: 0000883975
- company_name: Microbot Medical Inc.
- filed_at: 2025-09-16T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 1.01, 3.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/883975/000149315225013743/0001493152-25-013743-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/883975/000149315225013743/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-25-013743
- JSON: https://secwatch.observer/filing/0001493152-25-013743.json
- Plain text: https://secwatch.observer/filing/0001493152-25-013743.txt

## Key facts
- Equity Issuances
  Microbot Medical Inc. issued 225,000 shares of Common Stock of common stock to holders of Series H preferred investment options for exercise price per share of $2.10, generating gross proceeds of $472,500.
  - Security: common stock
  - Shares: 225,000 shares of Common Stock
  - Purchaser: holders of Series H preferred investment options
  - Consideration: exercise price per share of $2.10, generating gross proceeds of $472,500
  source text: On September 8, 2025, the Company issued 225,000 shares of Common Stock upon the exercise of a like number of Series H preferred investment options (the “Series H Options”) by the holders of such options. The exercise price per share of the Series H options was $2.10, generating gross proceeds to the Company, before deducting placement agent fees and expenses, of $472,500
  evidence_url: https://www.sec.gov/Archives/edgar/data/883975/000149315225013743/0001493152-25-013743-index.htm
- Equity Issuances
  Microbot Medical Inc. issued to purchase up to an aggregate of 13,989,115 shares of Common Stock of warrant to certain holders (the Holders) of existing series F, G, H and I preferred investment options for exercise of Existing PIOs at exercise prices ranging from $1.50 to $2.13 per share.
  - Security: warrant
  - Shares: to purchase up to an aggregate of 13,989,115 shares of Common Stock
  - Purchaser: certain holders (the Holders) of existing series F, G, H and I preferred investment options
  - Consideration: exercise of Existing PIOs at exercise prices ranging from $1.50 to $2.13 per share
  source text: the Holder exercised for cash its Existing PIOs to purchase an aggregate of 13,989,115 shares of Common Stock, at exercise prices ranging from $1.50 to $2.13 per share, in consideration for the Company’s agreement to issue new series J preferred investment options (the “New PIOs”) to purchase up to an aggregate of 13,989,115 shares of Common Stock (the “New PIO Shares”) at an exercise price of $4.50 per share
  evidence_url: https://www.sec.gov/Archives/edgar/data/883975/000149315225013743/0001493152-25-013743-index.htm
- Equity Issuances
  Microbot Medical Inc. issued preferred investment options to purchase an aggregate of (i) 10,362 shares of Common Stock at an exercise price of $1.875 (ii) 31,429 shares of Common Stock at of warrant to H.C. Wainwright & Co., LLC for cash fee equal to 7.0% of the gross proceeds received by the Company from the Offerings, plus a management fee equal to 1.0% of the gross proceeds.
  - Security: warrant
  - Shares: preferred investment options to purchase an aggregate of (i) 10,362 shares of Common Stock at an exercise price of $1.875 (ii) 31,429 shares of Common Stock at
  - Purchaser: H.C. Wainwright & Co., LLC
  - Consideration: cash fee equal to 7.0% of the gross proceeds received by the Company from the Offerings, plus a management fee equal to 1.0% of the gross proceeds
  source text: shares of the Common Stock issuable upon exercise of the Existing PIOs are registered pursuant to the post-effective amendments on Form S-3 to registration statements on Form S-1 (File Nos. 333-280113 and 333-284688) and the registration statement on Form S-3 (File No. 333-285690), declared effective by the SEC on July 3, 2024, April 2, 2025 and April 1,
  evidence_url: https://www.sec.gov/Archives/edgar/data/883975/000149315225013743/0001493152-25-013743-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.